嗅觉训练结果中与年龄有关的差异:前瞻性队列研究

IF 7.2 2区 医学 Q1 OTORHINOLARYNGOLOGY International Forum of Allergy & Rhinology Pub Date : 2024-09-12 DOI:10.1002/alr.23451
Amelia S. Lawrence, Jodi Veach, Rahul Alapati, Celina G. Virgen, Robert Wright, Frank Materia, Jennifer A. Villwock
{"title":"嗅觉训练结果中与年龄有关的差异:前瞻性队列研究","authors":"Amelia S. Lawrence, Jodi Veach, Rahul Alapati, Celina G. Virgen, Robert Wright, Frank Materia, Jennifer A. Villwock","doi":"10.1002/alr.23451","DOIUrl":null,"url":null,"abstract":"IntroductionWhile olfactory function decreases with age, it is unknown how age affects olfactory training (OT) efficacy. This study compared OT in two cohorts of subjects: aged ≤50 (younger cohort) and aged 51+ (older cohort) with olfactory dysfunction (OD) primarily from COVID‐19 infection.MethodsSubjects with OD primarily secondary to COVID‐19 infection were prospectively recruited and enrolled into an OT registry. Baseline data were collected and they were provided with a training kit and asked to complete OT at home twice daily for 6 months. Participants were asked to follow‐up at 3 and 6 months during training for olfactory testing and quality‐of‐life surveys (Sino‐Nasal Outcomes Test‐22 [SNOT‐22] and Questionnaire of Olfactory Disorders Negative Statements [QoD‐NS]).ResultsFifty‐six participants completed OT (younger cohort: <jats:italic>n</jats:italic> = 26, older cohort: <jats:italic>n</jats:italic> = 30). There were no significant differences between cohorts’ Affordable Rapid Olfactory Measurement Array (AROMA), QoD‐NS, or SNOT‐22 scores at any time point. Both cohorts showed significant AROMA score improvement of more than 16 points from baseline to 3 months (younger cohort: <jats:italic>p</jats:italic> = 0.001; older cohort: <jats:italic>p</jats:italic> = 0.008). The younger cohort had significant improvements in QoD‐NS (<jats:italic>p</jats:italic> = 0.008) and SNOT‐22 (<jats:italic>p</jats:italic> = 0.042) between baseline and 3 months while the older cohort improved from 3 to 6 months (QoD‐NS: <jats:italic>p</jats:italic> = 0.027, SNOT‐22: <jats:italic>p</jats:italic> = 0.049).ConclusionBoth cohorts demonstrated similar significant improvement in olfactory function after 3 months of OT. The timeline of subjective improvement was different between cohorts, with younger patients experiencing earlier improvement.","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"71 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Age‐related differences in olfactory training outcomes: A prospective cohort study\",\"authors\":\"Amelia S. Lawrence, Jodi Veach, Rahul Alapati, Celina G. Virgen, Robert Wright, Frank Materia, Jennifer A. Villwock\",\"doi\":\"10.1002/alr.23451\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IntroductionWhile olfactory function decreases with age, it is unknown how age affects olfactory training (OT) efficacy. This study compared OT in two cohorts of subjects: aged ≤50 (younger cohort) and aged 51+ (older cohort) with olfactory dysfunction (OD) primarily from COVID‐19 infection.MethodsSubjects with OD primarily secondary to COVID‐19 infection were prospectively recruited and enrolled into an OT registry. Baseline data were collected and they were provided with a training kit and asked to complete OT at home twice daily for 6 months. Participants were asked to follow‐up at 3 and 6 months during training for olfactory testing and quality‐of‐life surveys (Sino‐Nasal Outcomes Test‐22 [SNOT‐22] and Questionnaire of Olfactory Disorders Negative Statements [QoD‐NS]).ResultsFifty‐six participants completed OT (younger cohort: <jats:italic>n</jats:italic> = 26, older cohort: <jats:italic>n</jats:italic> = 30). There were no significant differences between cohorts’ Affordable Rapid Olfactory Measurement Array (AROMA), QoD‐NS, or SNOT‐22 scores at any time point. Both cohorts showed significant AROMA score improvement of more than 16 points from baseline to 3 months (younger cohort: <jats:italic>p</jats:italic> = 0.001; older cohort: <jats:italic>p</jats:italic> = 0.008). The younger cohort had significant improvements in QoD‐NS (<jats:italic>p</jats:italic> = 0.008) and SNOT‐22 (<jats:italic>p</jats:italic> = 0.042) between baseline and 3 months while the older cohort improved from 3 to 6 months (QoD‐NS: <jats:italic>p</jats:italic> = 0.027, SNOT‐22: <jats:italic>p</jats:italic> = 0.049).ConclusionBoth cohorts demonstrated similar significant improvement in olfactory function after 3 months of OT. The timeline of subjective improvement was different between cohorts, with younger patients experiencing earlier improvement.\",\"PeriodicalId\":13716,\"journal\":{\"name\":\"International Forum of Allergy & Rhinology\",\"volume\":\"71 1\",\"pages\":\"\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Forum of Allergy & Rhinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/alr.23451\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Forum of Allergy & Rhinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alr.23451","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

引言虽然嗅觉功能会随着年龄的增长而下降,但年龄对嗅觉训练(OT)效果的影响尚不清楚。本研究比较了两组受试者的嗅觉训练效果:年龄在 50 岁以下(年轻组)和 51 岁以上(年长组)的受试者,他们的嗅觉功能障碍(OD)主要是由 COVID-19 感染引起的。收集基线数据后,向他们提供一套训练工具,要求他们在 6 个月内每天两次在家完成 OT。在训练期间,要求参与者在 3 个月和 6 个月时进行随访,以进行嗅觉测试和生活质量调查(Sino-Nasal Outcomes Test-22 [SNOT-22] 和嗅觉障碍负面陈述问卷 [QoD-NS])。结果56 名参与者完成了 OT(年轻组群:n = 26,年长组群:n = 30)。在任何时间点,不同组别的平价快速嗅觉测量阵列 (AROMA)、QoD-NS 或 SNOT-22 分数均无明显差异。从基线到 3 个月期间,两个组群的 AROMA 分数都有明显提高,提高幅度超过 16 分(年轻组群:P = 0.001;年长组群:P = 0.008)。从基线到 3 个月期间,年轻组群的 QoD-NS (p = 0.008)和 SNOT-22 (p = 0.042)均有显著改善,而年长组群则从 3 个月到 6 个月期间均有改善(QoD-NS:p = 0.027,SNOT-22:p = 0.049)。两组患者的主观改善时间不同,年轻患者的改善时间更早。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Age‐related differences in olfactory training outcomes: A prospective cohort study
IntroductionWhile olfactory function decreases with age, it is unknown how age affects olfactory training (OT) efficacy. This study compared OT in two cohorts of subjects: aged ≤50 (younger cohort) and aged 51+ (older cohort) with olfactory dysfunction (OD) primarily from COVID‐19 infection.MethodsSubjects with OD primarily secondary to COVID‐19 infection were prospectively recruited and enrolled into an OT registry. Baseline data were collected and they were provided with a training kit and asked to complete OT at home twice daily for 6 months. Participants were asked to follow‐up at 3 and 6 months during training for olfactory testing and quality‐of‐life surveys (Sino‐Nasal Outcomes Test‐22 [SNOT‐22] and Questionnaire of Olfactory Disorders Negative Statements [QoD‐NS]).ResultsFifty‐six participants completed OT (younger cohort: n = 26, older cohort: n = 30). There were no significant differences between cohorts’ Affordable Rapid Olfactory Measurement Array (AROMA), QoD‐NS, or SNOT‐22 scores at any time point. Both cohorts showed significant AROMA score improvement of more than 16 points from baseline to 3 months (younger cohort: p = 0.001; older cohort: p = 0.008). The younger cohort had significant improvements in QoD‐NS (p = 0.008) and SNOT‐22 (p = 0.042) between baseline and 3 months while the older cohort improved from 3 to 6 months (QoD‐NS: p = 0.027, SNOT‐22: p = 0.049).ConclusionBoth cohorts demonstrated similar significant improvement in olfactory function after 3 months of OT. The timeline of subjective improvement was different between cohorts, with younger patients experiencing earlier improvement.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.70
自引率
10.90%
发文量
185
审稿时长
6-12 weeks
期刊介绍: International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.
期刊最新文献
Social factors associated with aspirin desensitization and diagnosis age in aspirin-exacerbated respiratory disease. Reply to: "Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta-analysis". Aging and frailty are associated with inflammatory endotypic shifts in patients with chronic rhinosinusitis. Hops bitter β-acids have antibacterial effects against sinonasal Staphylococcus aureus but also induce sinonasal cilia and mitochondrial dysfunction. Pathologic dural invasion is associated with regional recurrence in olfactory neuroblastoma: A multi-institutional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1